No reviews yet. Be the first to rate Takafumi!
Tottori University researchers unveil FUVAC121, a fusogenic oncolytic vaccinia virus achieving 72% complete remission in metastatic models via immune activation.
Photo by Ling App on Unsplash
Photo by Hermes Rivera on Unsplash
Photo by Maccy on Unsplash
Photo by Chanelle on Unsplash
Photo by Marek Pavlík on Unsplash
Photo by World Wanderer on Unsplash
Photo by Artfox Photography on Unsplash
See Research & Publication News in Your CountrySee more Research & Publication News Articles
Have a story or a research paper to share? Become a contributor and publish your work on AcademicJobs.com.
Submit your Research - Make it Global News